Intraductal Papillary Mucinous Neoplasms of the Pancreas: An Updated Experience
By T. Sohn, C. Yeo, John L. Cameron, R. Hruban, N. Fukushima, K. Campbell, K. Lillemoe. Annals of Surgery, 2004
906 citations recorded by the source corpus.
View Paper: https://www.semanticscholar.org/paper/115451e71ae7acbab4b5d624adf25843336b3d6f
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
- M. Canto
- R. Hruban
- F. Harinck
- M. Goggins
- G. Offerhaus
- J. Poley
- I. Kamel
- Y. Nio
Citations in the corpus
- International consensus guidelines 2012 for the management of IPMN and MCN of the pancreas. (2012, neutral): “4%) Sohna,[12] 2004 136 >52 (38.”
- International Cancer of the Pancreas Screening (CAPS) Consortium summit on the management of patients with increased risk for familial pancreatic cancer (2012, background): “57 However, follow-up imaging was recommended less than 6 months after surgery if there was any PanIN-3 in the resected pancreas of individuals without PC.”